CTCBIO Inc. (KOSDAQ: 060590)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,320.00
-260.00 (-3.95%)
Dec 20, 2024, 9:00 AM KST
-34.64%
Market Cap 151.10B
Revenue (ttm) 138.95B
Net Income (ttm) -16.79B
Shares Out 23.91M
EPS (ttm) -702.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 60,197
Open 6,610.00
Previous Close 6,580.00
Day's Range 6,270.00 - 6,650.00
52-Week Range 6,000.00 - 11,730.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 20, 2025

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 249
Stock Exchange KOSDAQ
Ticker Symbol 060590
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.